These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10217582)
41. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313 [TBL] [Abstract][Full Text] [Related]
42. Bioinspired Silica Mineralization on Viral Templates. Dickmeis C; Altintoprak K; van Rijn P; Wege C; Commandeur U Methods Mol Biol; 2018; 1776():337-362. PubMed ID: 29869253 [TBL] [Abstract][Full Text] [Related]
43. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Sinha B; François PP; Nüsse O; Foti M; Hartford OM; Vaudaux P; Foster TJ; Lew DP; Herrmann M; Krause KH Cell Microbiol; 1999 Sep; 1(2):101-17. PubMed ID: 11207545 [TBL] [Abstract][Full Text] [Related]
44. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Dziewanowska K; Patti JM; Deobald CF; Bayles KW; Trumble WR; Bohach GA Infect Immun; 1999 Sep; 67(9):4673-8. PubMed ID: 10456915 [TBL] [Abstract][Full Text] [Related]
45. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. Marusic C; Rizza P; Lattanzi L; Mancini C; Spada M; Belardelli F; Benvenuto E; Capone I J Virol; 2001 Sep; 75(18):8434-9. PubMed ID: 11507188 [TBL] [Abstract][Full Text] [Related]
46. [GAPDH activity and immunogenicity of Staphylococcus aureus recombinant GapC protein]. Zhu H; Zhu Z; Cui Y; Zhang J; Liu L; Piao F Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):754-9. PubMed ID: 18724693 [TBL] [Abstract][Full Text] [Related]
47. Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine. Carignan D; Thérien A; Rioux G; Paquet G; Gagné ML; Bolduc M; Savard P; Leclerc D Vaccine; 2015 Dec; 33(51):7245-7253. PubMed ID: 26549362 [TBL] [Abstract][Full Text] [Related]
48. Interaction of fibronectin and fibronectin binding protein (FnBP) of Staphylococcus aureus with murine phagocytes and lymphocytes. Rozalska B; Wadström T FEMS Microbiol Immunol; 1992 Aug; 4(6):305-15. PubMed ID: 1388034 [TBL] [Abstract][Full Text] [Related]
49. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA. Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778 [TBL] [Abstract][Full Text] [Related]
50. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330 [TBL] [Abstract][Full Text] [Related]
51. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus. Yasawardene SG; Lomonossoff GP; Ramasamy R Indian J Med Res; 2003 Sep; 118():115-24. PubMed ID: 14700344 [TBL] [Abstract][Full Text] [Related]
52. Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus. Gaudreau MC; Lacasse P; Talbot BG Vaccine; 2007 Jan; 25(5):814-24. PubMed ID: 17027124 [TBL] [Abstract][Full Text] [Related]
53. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments. Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747 [TBL] [Abstract][Full Text] [Related]
55. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Brouillette E; Lacasse P; Shkreta L; Bélanger J; Grondin G; Diarra MS; Fournier S; Talbot BG Vaccine; 2002 May; 20(17-18):2348-57. PubMed ID: 12009291 [TBL] [Abstract][Full Text] [Related]
56. Use of viral vectors for vaccine production in plants. Cañizares MC; Nicholson L; Lomonossoff GP Immunol Cell Biol; 2005 Jun; 83(3):263-70. PubMed ID: 15877604 [TBL] [Abstract][Full Text] [Related]
57. Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18. Yin RL; Li C; Yang ZT; Zhang YJ; Bai WL; Li X; Yin RH; Liu H; Liu S; Yang Q; Cao YG; Zhang NS Vet Immunol Immunopathol; 2009 Dec; 132(2-4):270-4. PubMed ID: 19540000 [TBL] [Abstract][Full Text] [Related]
58. Characterization of adhesive epitopes with the OmpS display system. Lång H; Mäki M; Rantakari A; Korhonen TK Eur J Biochem; 2000 Jan; 267(1):163-70. PubMed ID: 10601863 [TBL] [Abstract][Full Text] [Related]
59. Recombinant protein YbgF induces protective immunity against Rickettsia heilongjiangensis infection in C3H/HeN mice. Qi Y; Xiong X; Duan C; Jiao J; Gong W; Wen B Vaccine; 2013 Nov; 31(48):5643-50. PubMed ID: 24113261 [TBL] [Abstract][Full Text] [Related]
60. Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response. Schulze K; Medina E; Talay SR; Towers RJ; Chhatwal GS; Guzmán CA Infect Immun; 2001 Jan; 69(1):622-5. PubMed ID: 11119566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]